Acrivon Therapeutics, Inc. Common Stock
Healthcare
NASDAQ:ACRV · NASDAQ Global Market
Market Cap $54.28M Beta 1.91 P/E (TTM) -0.8
$1.72 +3.16%
+$0.05 today
52W Low $1.15High $3.56
Vol 0.26M · Avg 0.60M
EPS (TTM) -$2.00Biotechnology
Stock Analysis
Build a private investment thesis
Answer the Know the Business, Test the Moat, Management, and Intrinsic Value questions before deciding whether the stock deserves capital.
Use this checklist to turn Acrivon Therapeutics, Inc. Common Stock research into a structured thesis instead of a loose collection of notes. The questions below help you connect the business model, competitive position, management behavior, financial quality, and valuation assumptions for ACRV before you decide whether the opportunity is attractive, too uncertain, or already priced for perfection.
Log in to save your stock analysis
Your answers are private and saved per stock, so you can come back to the thesis later.
Explore More
Continue the stock analysis
Jump to another research area for this company.
OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.FilingsOpen recent filings alongside price history for deeper research.